Monogram Technologies Inc. — Regulatory Filings 2023

May 17, 2023

8-A12B 1 tm2315910d1_8a12b.htm 8-A12B

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

Monogram Orthopaedics Inc.

(Exact name of registrant as specified in its charter)

Delaware	81-2349540
(State of incorporation or organization)	(I.R.S. Employer Identification No.)

3913 Todd Lane, Suite 307 Austin, Texas	78744
(Address of principal executive offices)	(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered	Name of each exchange on which each class is to be registered
Common Stock, $0.001 par value per share	The NASDAQ Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A(d), check the following box. ¨

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. x

Securities Act registration statement or Regulation A offering statement file number to which this form relates: Form 1-A, File No, 024-12084

Securities to be registered pursuant to Section 12(g) of the Act: None

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 1. Description of Registrant’s Securities to be Registered.

Monogram Orthopaedics Inc. (the “Registrant”) hereby incorporates by reference the description of its Common Stock, to be registered hereunder, as set forth under the heading “Securities Being Offered” in the offering circular included in the Registrant’s Offering Statement on Form 1-A (File No. 024-12084), filed with the U.S. Securities and Exchange Commission on May 11, 2023, as amended or supplemented.

Item 2. Exhibits.

In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

Field: Page; Sequence: 2

Field: /Page

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

Date: May 17, 2023

Registrant: Monogram Orthopaedics Inc.
By:	/s/ Benjamin Sexson
Name:	Benjamin Sexson
Title:	Chief Executive Officer

Field: Page; Sequence: 3; Options: Last

Field: /Page